Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Inclusive dermatology aims to provide personalized skin care for all by addressing diverse needs and disparities.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Gut bacteria differences could help diagnose and treat alopecia areata.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Exosomes could be effective for improving skin health and treating skin diseases.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Yangyin Qingre Huoxue Prescription may help treat atherosclerosis with fewer liver side effects than simvastatin.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Splitting one hair follicle into two can help regrow hair with a 50% to 70% success rate, useful when donor hair is limited.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Dupilumab helps children with alopecia areata regrow hair safely.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Hairless mammals have genetic changes in both their protein-coding and regulatory sequences related to hair.

Belimumab effectively controls SLE disease activity and reduces steroid use.